Congratulations to our 2026 Fellows’ Choice award winners! 🎉
Each year, fellows recognize faculty who have made a meaningful impact on their education—those who go above and beyond to teach and inspire.
👏 Teacher of the Year: Dr. Doug Simonetto
👏 Endoscopy Teacher of the Year: Dr. Dan Maselli
Please join us in congratulating them on this well-deserved recognition!
This curve brought me to tears.
I treated a patient on this trial, and it took his terrible pain away completely within days, which is simply not common.
This represents decades of scientific perseverance and millions of patients who will now live longer and with less pain. 👏🏻
This updated Delphi consensus helps move MASLD/MASH care toward a more pragmatic and scalable fibrosis-centered model based on non-invasive testing, longitudinal monitoring, and real-world implementation. https://t.co/Z6ondjnSQp
MASLD guidelines agree on what to do: lose weight, move more, eat better. They largely ignore what actually determines success: mental health, environment, and social context.
We don��t have a knowledge gap.
We have an implementation gap.
@IDIVALdecilla @sepdigestiva @AEEHLiver
Fascinating paper just published in Science.
The authors analyze the career trajectories of top performers across multiple domains, including Nobel laureates, elite chess players, Olympic gold medalists, and more.
Their central finding challenges a common belief.
Intensive, single-discipline training at a young age does confer an early advantage, but this advantage fades over time.
By contrast, individuals exposed to multidisciplinary practice early in life tend to start more slowly. Yet, over the long run, they are more likely to reach world-class performance, eventually overtaking early specialists, who often plateau just below the very top.
An important reminder that breadth early on can be a powerful investment in long-term excellence.
Link to the paper in the first reply.
🗣️The high prevalence of #SLD shows that there remains an urgent need for targeted public health interventions and policies to address the modifiable risk factors contributing to the global burden of SLD.
🔗:https://t.co/iFSkSeFu0L
📣SLD subclassifications (MASLD, MetALD, ALD) are dynamic—38% of individuals were reclassified over 2 years, with >60% of MetALD and ALD reclassified. Regular reassessment is key for accurate diagnosis, treamtent & trial eligibility.
🔗: https://t.co/4H2WwMZQdh
And check our paper on Obeticholic Acid for Primary Biliary Cholangitis. An analysis of efficacy and safety in more than 1,200 patients 🎄🎅
https://t.co/N354SxP4Tc
Check out the December issue of the Journal of #Gastroenterology and #Hepatology 📗🎄 #TealJournal
❇️ Impact of Liraglutide on MASLD
❇️ IT Knife in ESD Procedure Time
❇️ Amyloidosis for GIs
❇️ Determinants of Shorter Colonoscopy Intervals
And more 🔗 https://t.co/v7dv5MTMKT
Artículo de revisión
Trasplante hepático en enfermedades hepatobiliares colestásicas: momento óptimo y recurrencia de la enfermedad
Cançado et al
#LiverX
https://t.co/dugSCXdiLo
Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.
🤔 Is obeticholic acid safe and effective for patients with PBC?
🔎 Our recent meta-analysis, enrolling 1,285 patients, showed that 37% of patients respond to the therapy, with an attenuated response seen in real-world settings.
#LiverTwitter
https://t.co/N354SxP4Tc
Hi #MedTwitter!
I’m Diego, an IMG from 🇧🇷 and researcher at @MayoClinicGIHep.
Applying for Internal Medicine in the #Match2026!
Driven by patient-centered care, teaching & leadership. Sports enthusiast! 🎾⚽️🏃
Excited to connect with programs and applicants! 😁
Hi #MedTwitter! Excited to be applying for #InternalMedicine this #Match2026.
I'm Ray Portela, a Brazilian graduate and postdoctoral research fellow at @MayoClinic. Grateful for my family and mentors during this journey.
Wishing everyone the best of luck this interview season!
Hi #MedTwitter!
I’m Rafael Santos, MD from Brazil 🇧🇷, applying to IM in #Match2026.
Grateful to my mentors, professors, and family for guiding me here.
Passionate about patient-centered care and teaching.
Excited to connect with colleagues in the field!
#InternalMedicine#IMG
Hi #MedX#MedTwitter.
I’m Eliabe Abreu, a 2022 graduate from Brazil 🇧🇷, and a Research Fellow at the Mayo Clinic (GI & Hep). I am applying for #InternalMedicine in the #Match2026. AAMC ID: 16714525
Best wishes to all applicants!